ReviewAntibiotics (Basel, Switzerland)2026
Metformin as a Metabolic Reprogramming Interface in Host-Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss.
Shakta Mani Satyam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.